Position in ASND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,749,799
+$154,360 QoQ
Shares Held
16,394
-2.8% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITAL INTERNATIONAL LTD /CA/ holds $119,458,337 across 7 Biotechnology names. ASND ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
95,874 | $42,811,575 | |
| 2 | RPRX |
Royalty Pharma plc
|
570,577 | $27,370,578 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
76,515 | $22,722,659 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,610 | $10,515,630 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,078 | $9,621,037 | |
| 6 | ASND |
Ascendis Pharma A/S
This page
|
16,394 | $3,749,799 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
56,066 | $2,667,059 |
All Filings in ASND
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,749,799 | 16,394 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,595,439 | 16,861 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,308,610 | 21,672 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,537,954 | 20,498 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,148,527 | 20,201 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,636,793 | 19,153 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||